Methotrexate Therapy and Pregnancy Planning
General Recommendations
- The American Academy of Dermatology recommends that women should wait at least 3 months after discontinuing methotrexate before attempting to conceive to ensure complete clearance from hepatic and other tissues 1, 2, 3
- The British Association of Dermatologists also recommends a 3-month waiting period, allowing methotrexate to be fully cleared from the liver and other maternal tissues 1, 3, 4
- Methotrexate is FDA Pregnancy Category X and causes specific embryopathy, including cardiac, skeletal, and central nervous system defects 4
- The teratogenic risk from maternal methotrexate exposure is highest within the first 6 to 8 weeks of pregnancy 1, 2
Pre-Conception Management
- The American Academy of Dermatology recommends stopping methotrexate immediately when pregnancy planning begins 1, 2, 3
- Women of childbearing potential should use two methods of contraception throughout the 3-month waiting period 3
- Pregnancy tests should be performed prior to starting methotrexate therapy in women of childbearing potential 3
- Folic acid supplementation should be continued or initiated to reduce methotrexate-related adverse effects 5
Paternal Exposure
- The British Journal of Dermatology recommends that men should also wait at least 3 months after their last methotrexate dose before attempting to conceive 3, 4
- One complete cycle of spermatogenesis requires 74 days, making the 3-month waiting period physiologically appropriate 4
- Prospective studies have found no increased risk of spontaneous abortion or fetal malformations with paternal methotrexate exposure 3
Pregnancy Occurrence During Methotrexate Treatment
- Methotrexate should be discontinued immediately upon pregnancy confirmation 5
- Folic acid supplementation should be initiated or continued 5
- Urgent referral for obstetric counseling is recommended, preferably to a high-risk obstetrics program 5
Special Considerations
- The American Academy of Dermatology recommends that conception should be delayed for at least 3 months after methotrexate treatment for ectopic pregnancy 3, 4
- Despite emerging research suggesting shorter intervals may be safe, the 3-month waiting period remains the standard recommendation to ensure safety 3, 4